Year archive

Oncoinvent ASA — 2026 filings

All 27 regulatory filings released by Oncoinvent ASA (OCIN) in 2026, sourced directly from the official regulator.

27 Filings

2026 Period

2026 filings (27)

Filing	Released	Lang
Oncoinvent ASA: Grant of share options to member of the Board following AGM - Attachment: PDMR_notifications_20_May_2026_grant_of_board_options.pdf Director's Dealing	2026-05-20	English
Oncoinvent ASA: Grant of share options to member of the Board following AGM Director's Dealing	2026-05-20	English
Oncoinvent ASA: Minutes from Annual General Meeting - Attachment: Oncoinvent_ASA_Minutes_of_Annual_General_Meeting_20_May_2026_signed.pdf AGM Information	2026-05-20	Norwegian Bokmål
Oncoinvent ASA: Minutes from Annual General Meeting Report Publication Announcement	2026-05-20	English
Oncoinvent ASA: Share capital decrease completed Declaration of Voting Results & Voting Rights Announcements	2026-05-05	Norwegian
Oncoinvent presents corporate update in live webcast Investor Presentation	2026-04-29	English
Oncoinvent ASA: Notice of Annual General Meeting - Attachment: Oncoinvent_ASA_Notice_to_AGM_2026_final.pdf Proxy Solicitation & Information Statement	2026-04-28	Norwegian
Oncoinvent ASA: Notice of Annual General Meeting Proxy Solicitation & Information Statement	2026-04-28	English
Oncoinvent ASA: Invitation to business update Wednesday 29 April 2026 Report Publication Announcement	2026-04-23	English
Oncoinvent secures new patent expanding protection for Radspherin[®] Regulatory Filings	2026-03-19	English
Oncoinvent ASA: Grant of share options to the CEO - Attachment: Attachment_PDMR_form_Oystein_Soug_CEO.pdf Director's Dealing	2026-03-11	English
Oncoinvent ASA: Grant of share options to the CEO Director's Dealing	2026-03-11	English
Oncoinvent ASA: Second half 2025 results - Attachment: 20260226_Oncoinvent_2H25_presentation.pdf Investor Presentation	2026-02-26	English
Oncoinvent ASA: Second half 2025 results - Attachment: 20260226_Oncoinvent_2H_2025_report.pdf Interim / Quarterly Report H2 2025	2026-02-26	English
Oncoinvent ASA: Second half 2025 results Earnings Release H2 2025	2026-02-26	English
Oncoinvent to Present Positive 24-month Follow-up Data from Phase 1 Ovarian Cancer Study of Radspherin[®] at ESGO 2026 Regulatory Filings	2026-02-17	English
Financial calendar Report Publication Announcement	2026-02-03	English
Finansiell kalender Report Publication Announcement	2026-02-03	Norwegian
Four additional sites open for recruitment in Oncoinvent's Phase 2 trial Regulatory Filings	2026-01-29	English
Oncoinvent ASA: Registration of reverse share split Share Issue/Capital Change	2026-01-20	English
Oncoinvent ASA: Ex. reverse share split and change of ISIN today Share Issue/Capital Change	2026-01-19	English
Oncoinvent ASA - New share capital registered Share Issue/Capital Change	2026-01-15	English
Oncoinvent ASA: Key information relating to the reverse share split and change of ISIN Share Issue/Capital Change	2026-01-14	English
Oncoinvent ASA: Grant of share options to new CFO - Attachment: Attachment_PDMR_form_Ramzi_Amri.pdf Director's Dealing	2026-01-13	English
Oncoinvent ASA: Grant of share options to new CFO Director's Dealing	2026-01-13	English
Oncoinvent ASA: Minutes from Extraordinary General Meeting - Attachment: Oncoinvent_ASA_EGM_Minutes_08_01_26.pdf Declaration of Voting Results & Voting Rights Announcements	2026-01-08	Norwegian
Oncoinvent ASA: Minutes from Extraordinary General Meeting AGM Information	2026-01-08	English